QNTM
Quantum BioPharma Ltd. (QNTM) ESG Analysis Analysis (2026)
No material changes this month.
Overall Score
Environmental
No material environmental disclosures or sustainability metrics were provided in the fresh data.
The company remains too small and financially distressed to infer meaningful environmental progress from the available financials.
Social
No material social or workforce disclosures were provided in the fresh data.
The available metrics do not indicate a clear month-over-month change in employee, customer, or community impact.
Governance
No material governance updates or news items were provided this month.
Capital structure remains modestly levered with debt-to-equity at 0.12 and current ratio at 1.20, but profitability and cash generation remain weak.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Quantum BioPharma Ltd.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.
